Search alternatives:
- Subject ("SGLT2 INHIBITORS") »
Loading…
Loading…
SGLT2 inhibitors and diabetic retinopathy progression
Nadelmann, Jennifer B., Miller, Charles G., McGeehan, Brendan, Yu, Yinxi, VanderBeek, Brian L.
Published in Graefe's archive for clinical and experimental ophthalmology (01.03.2024)
Published in Graefe's archive for clinical and experimental ophthalmology (01.03.2024)
Get full text
Journal Article
Loading…
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Neuen, Brendon L., Heerspink, Hiddo J.L., Vart, Priya, Claggett, Brian L., Fletcher, Robert A., Arnott, Clare, de Oliveira Costa, Julianna, Falster, Michael O., Pearson, Sallie-Anne, Mahaffey, Kenneth W., Neal, Bruce, Agarwal, Rajiv, Bakris, George, Perkovic, Vlado, Solomon, Scott D., Vaduganathan, Muthiah
Published in Circulation (New York, N.Y.) (06.02.2024)
Published in Circulation (New York, N.Y.) (06.02.2024)
Get full text
Journal Article
Loading…
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
Wright, Alison K., Carr, Matthew J., Kontopantelis, Evangelos, Leelarathna, Lalantha, Thabit, Hood, Emsley, Richard, Buchan, Iain, Mamas, Mamas A., van Staa, Tjeerd P., Sattar, Naveed, Ashcroft, Darren M., Rutter, Martin K.
Published in Diabetes care (01.04.2022)
Published in Diabetes care (01.04.2022)
Get full text
Journal Article
Loading…
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
Muller, Dion R. P., Stenvers, Dirk J., Malekzadeh, Arjan, Holleman, Frederik, Painter, Rebecca C., Siegelaar, Sarah E.
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Get full text
Journal Article
Loading…
Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
Lymperopoulos, Anastasios, Borges, Jordana I., Cora, Natalie, Sizova, Anastasiya
Published in International journal of molecular sciences (19.07.2021)
Published in International journal of molecular sciences (19.07.2021)
Get full text
Journal Article
Loading…
Loading…
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
Liu, Hongyan, Sridhar, Vikas S., Boulet, Jacinthe, Dharia, Atit, Khan, Abid, Lawler, Patrick R., Cherney, David Z.I.
Published in Metabolism, clinical and experimental (01.01.2022)
Published in Metabolism, clinical and experimental (01.01.2022)
Get full text
Journal Article
Loading…
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors
Wu, Mei-Zhen, Chandramouli, Chanchal, Wong, Pui-Fai, Chan, Yap-Hang, Li, Hang-Long, Yu, Si-Yeung, Tse, Yi-Kei, Ren, Qing-Wen, Yu, Shuk-Yin, Tse, Hung-Fat, Lam, Carolyn S.P., Yiu, Kai-Hang
Published in Diabetes & metabolism (01.11.2022)
Published in Diabetes & metabolism (01.11.2022)
Get full text
Journal Article
Loading…
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Mancinetti, Francesca, Xenos, Dionysios, De Fano, Michelantonio, Mazzieri, Alessio, Porcellati, Francesca, Boccardi, Virginia, Mecocci, Patrizia
Published in Ageing research reviews (01.09.2023)
Published in Ageing research reviews (01.09.2023)
Get full text
Journal Article
Loading…
Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
Tsai, Wen-Hsuan, Chuang, Shih-Ming, Liu, Sung-Chen, Lee, Chun-Chuan, Chien, Ming-Nan, Leung, Ching-Hsiang, Liu, Shu-Jung, Shih, Hong-Mou
Published in Scientific reports (28.07.2021)
Published in Scientific reports (28.07.2021)
Get full text
Journal Article
Loading…
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Palanca, Ana, van Nes, Falco, Pardo, Felipe, Ampudia Blasco, F. Javier, Mathieu, Chantal
Published in Diabetes care (01.03.2022)
Published in Diabetes care (01.03.2022)
Get full text
Journal Article
Loading…
Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data
Hallow, K. Melissa, Greasley, Peter J., Helmlinger, Gabriel, Chu, Lulu, Heerspink, Hiddo J., Boulton, David W.
Published in American journal of physiology. Renal physiology (01.11.2018)
Published in American journal of physiology. Renal physiology (01.11.2018)
Get full text
Journal Article
Loading…
Loading…
Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
Monda, Vincenzo Maria, Gentile, Sandro, Porcellati, Francesca, Satta, Ersilia, Fucili, Alessandro, Monesi, Marcello, Strollo, Felice
Published in Advances in therapy (01.11.2022)
Published in Advances in therapy (01.11.2022)
Get full text
Journal Article
Loading…
2495 Renal and peritoneal protective effects of SGLT2 Inhibitors in incident peritoneal dialysis (PD) patients
Ishioka, Kunihiro, Mitomo, Ayaka, Maruyama, Haruka, Hagiwara, Takayuki, Yamano, Mizuki, Mochida, Yasuhiro, Oka, Machiko, Maesato, Kyoko, Moriya, Hidekazu, Ohtake, Takayasu, Hidaka, Sumi, Kobayashi, Shuzo
Published in Nephrology Dialysis Transplantation (01.05.2024)
Published in Nephrology Dialysis Transplantation (01.05.2024)
Get full text
Journal Article
Loading…
37-OR: SGLT2 Inhibitors Exert Anti-inflammatory and Antioxidant Effects in Epicardial Adipose Tissue of Severe Heart Failure Subjects
MRAZ, MILOS, JUDITA KASPEROVA, BARBORA, STEMBERKOVA, SONA, SVOBODA, PETR, HLAVÁCEK, DANIEL, MAHRÍK, JAKUB, KUDA, ONDREJ, CAJKA, TOMAS, TOMANOVÁ, LUCIE, PLEYEROVA, IVETA, ROSOLOVÁ, KATERINA, NOVODVORSKY, PETER, IVAK, PETER, MELENOVSKY, VOJTECH, NETUKA, IVAN, HALUZIK, MARTIN
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
Loading…
Serum Proteome Profiling of Diabetic Patients Treated With DPP4 and SGLT2 Inhibitors Shows Improved Cognitive and Cardiovascular Functions
Hakim, Md Abdul, Sanni, Akeem, Osman, Shams T., Hamdy, Noha A., Purba, Waziha Tasnim, Bhuiyan, Md Mostofa Al Amin, Onigbinde, Sherifdeen, El‐Khordagui, Labiba K., El‐Yazbi, Ahmed, Mechref, Yehia
Published in Proteomics (Weinheim) (01.07.2025)
Published in Proteomics (Weinheim) (01.07.2025)
Get full text
Journal Article
Loading…
SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes
Bajaj, H.S., Brown, R.E., Bhullar, L., Sohi, N., Kalra, S., Aronson, R.
Published in Diabetes & metabolism (01.12.2018)
Published in Diabetes & metabolism (01.12.2018)
Get full text
Journal Article